CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 358 enrolled
Drug / intervention
AI-enabled ECG-based Screening Toolother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04000087
NCT04000087N/ACompleted
CompareCT.gov

Electrocardiogram Artificial Intelligence-Guided Screening for Low Ejection Fraction (EAGLE)

Mayo Clinic·interventional·Posted Jun 27, 2019·Updated May 31, 2023

In Brief

A clinical study evaluating AI-enabled ECG-based Screening Tool for Asymptomatic Left Ventricular Systolic Dysfunction (Disorder) and Heart Failure. Completed, enrolled 358 participants across 1 site.

Detailed Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsymptomatic Left Ventricular Systolic Dysfunction (Disorder), Heart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 27, 2019
Enrollment StartJun 26, 2019
Primary CompletionMar 31, 2020
Study CompletionNov 1, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.0 years ago

Interventions

AI-enabled ECG-based Screening Toolother

A novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.